NCT05444764View on ClinicalTrials.gov

PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Extracorporeal Membrane OxygenationExtracorporeal Membrane Oxygenation Complication
Trial Locations (6)

5623EJ

RECRUITING

Catharinaziekenhuis Eindhoven, Eindhoven

8025 AB

NOT_YET_RECRUITING

Isala Hospital, Zwolle

2300 RC

RECRUITING

Leids Universitair Medisch Centrum, Leiden

3015GD

RECRUITING

Erasmus Medisch Centrum, Rotterdam

3435CM

RECRUITING

Antoniusziekenhuis Nieuwegein, Nieuwegein

3584CX

RECRUITING

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Leiden University Medical Center

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

St. Antonius Hospital

OTHER

collaborator

Catharina Ziekenhuis Eindhoven

OTHER

collaborator

Isala

OTHER

lead

UMC Utrecht

OTHER

NCT05444764 - PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS | Biotech Hunter | Biotech Hunter